SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-216388
Filing Date
2021-07-15
Accepted
2021-07-15 16:13:05
Documents
15
Period of Report
2021-07-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d200433d8k.htm   iXBRL 8-K 28165
2 EX-99.1 d200433dex991.htm EX-99.1 7045
6 GRAPHIC g200433g04h70.jpg GRAPHIC 3026
7 GRAPHIC g200433g0715230322078.jpg GRAPHIC 2384
  Complete submission text file 0001193125-21-216388.txt   170773

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20210714.xsd EX-101.SCH 2913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20210714_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20210714_pre.xml EX-101.PRE 10967
8 EXTRACTED XBRL INSTANCE DOCUMENT d200433d8k_htm.xml XML 3275
Mailing Address 6200 LOOKOUT RD. BOULDER CO 80301
Business Address 6200 LOOKOUT RD. BOULDER CO 80301 720.643.5200
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36483 | Film No.: 211092837
SIC: 8071 Services-Medical Laboratories